Repository logo
 

Physical activity attenuates postprandial hyperglycaemia in homozygous TBC1D4 loss-of-function mutation carriers

Published version
Peer-reviewed

Change log

Authors

Schnurr, Theresia M.  ORCID logo  https://orcid.org/0000-0002-6573-4959
Jørsboe, Emil 
Chadt, Alexandra 
Dahl-Petersen, Inger K. 
Kristensen, Jonas M. 

Abstract

Abstract: Aims/hypothesis: The common muscle-specific TBC1D4 p.Arg684Ter loss-of-function variant defines a subtype of non-autoimmune diabetes in Arctic populations. Homozygous carriers are characterised by elevated postprandial glucose and insulin levels. Because 3.8% of the Greenlandic population are homozygous carriers, it is important to explore possibilities for precision medicine. We aimed to investigate whether physical activity attenuates the effect of this variant on 2 h plasma glucose levels after an oral glucose load. Methods: In a Greenlandic population cohort (n = 2655), 2 h plasma glucose levels were obtained after an OGTT, physical activity was estimated as physical activity energy expenditure and TBC1D4 genotype was determined. We performed TBC1D4–physical activity interaction analysis, applying a linear mixed model to correct for genetic admixture and relatedness. Results: Physical activity was inversely associated with 2 h plasma glucose levels (β[main effect of physical activity] −0.0033 [mmol/l] / [kJ kg−1 day−1], p = 6.5 × 10−5), and significantly more so among homozygous carriers of the TBC1D4 risk variant compared with heterozygous carriers and non-carriers (β[interaction] −0.015 [mmol/l] / [kJ kg−1 day−1], p = 0.0085). The estimated effect size suggests that 1 h of vigorous physical activity per day (compared with resting) reduces 2 h plasma glucose levels by an additional ~0.7 mmol/l in homozygous carriers of the risk variant. Conclusions/interpretation: Physical activity improves glucose homeostasis particularly in homozygous TBC1D4 risk variant carriers via a skeletal muscle TBC1 domain family member 4-independent pathway. This provides a rationale to implement physical activity as lifestyle precision medicine in Arctic populations. Data repository: The Greenlandic Cardio-Metabochip data for the Inuit Health in Transition study has been deposited at the European Genome-phenome Archive (https://www.ebi.ac.uk/ega/dacs/EGAC00001000736) under accession EGAD00010001428. Graphical abstract:

Description

Funder: Karen Elise Jensens Fond; doi: http://dx.doi.org/10.13039/501100004046


Funder: European Foundation for the Study of Diabetes; doi: http://dx.doi.org/10.13039/501100001648


Funder: NunaFonden


Funder: Danish Diabetes Academy; doi: http://dx.doi.org/10.13039/100015223


Funder: Lundbeckfonden; doi: http://dx.doi.org/10.13039/501100003554


Funder: Villum Fonden; doi: http://dx.doi.org/10.13039/100008398


Funder: Det Frie Forskningsråd; doi: http://dx.doi.org/10.13039/501100004836


Funder: Steno Diabetes Center


Funder: Commission for Scientific Research Greenland


Funder: Novo Nordisk Foundation Center for Basic Metabolic Research; doi: http://dx.doi.org/10.13039/501100011747


Funder: Medical Research Council Greenland


Funder: Medical Research Council Denmark

Keywords

Article, Arctic, Gene-environment interaction, Lifestyle therapy, Physical activity, Postprandial hyperglycaemia, TBC1D4 loss-of-function

Journal Title

Diabetologia

Conference Name

Journal ISSN

0012-186X
1432-0428

Volume Title

64

Publisher

Springer Berlin Heidelberg
Sponsorship
Medical Research Council (MC UU 12015/3)
Novo Nordisk Fonden (NNF16OC0019986)